Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Juraj, Pechan"'
Autor:
Patrik Palacka, Monika Pol’anová, Alena Svobodová, Jan Žigmond, Katarína Zanchetta, Vlasta Gombárová, Martina Vulganová, Ján Slopovský, Jana Obertová, Ľuboš Drgoňa, Michal Mego, Juraj Pechan
Publikováno v:
Vaccines, Vol 10, Iss 4, p 558 (2022)
Vaccination remains the leading strategy against COVID-19 worldwide. BNT162b2 is among the first licensed vaccines with high effectiveness. However, the role of antibody and cell immunity response monitoring after vaccination remains unclear. We cond
Externí odkaz:
https://doaj.org/article/34779625ae434ebd84a5f67ca6cde37c
Autor:
Andrej, DOBROVODSKY1 andrej.dobrovodsky@fntt.sk, Juraj, PECHAN1, Marian, DUFFEK1, Radovan, SKUTA1, Rastislav, HUSTAK1
Publikováno v:
Bratislava Medical Journal / Bratislavské Lekárske Listy. 2022, Vol. 123 Issue 6, p389-394. 6p.
Publikováno v:
BMC Surgery, Vol 17, Iss 1, Pp 1-5 (2017)
Abstract Background Limited data are available on the importance of routine lymphadenectomy of the hepatoduodenal ligament in the treatment of liver metastasis from colorectal cancer in the literature. Methods A single center retrospective cohort stu
Externí odkaz:
https://doaj.org/article/b34321bd8ce748c299ddf71949a611e9
Autor:
Patrik Palacka, Monika Polanova, Alena Svobodova, Jan Zigmond, Katarina Zanchetta, Vlasta Gombarova, Martina Vulganova, Jan Slopovsky, Jana Obertova, Michal Mego, Lubos Drgona, Juraj Pechan
Publikováno v:
Journal of Clinical Oncology. 40:e18774-e18774
e18774 Background: Vaccination remains the leading strategy against Covid-19 worldwide. BNT 162b2 (tozinameran) belongs among first licensed vaccines with good efficacy. However, the role of monitoring both, antibodies and cell immunity after vaccina
Autor:
Michal Mego, Katarina Zanchetta, Juraj Pechan, Vladimira Baranova, Jan Slopovsky, Beata Bernadicova, Eva Badurikova, Lubos Drgona, Patrik Palacka
Publikováno v:
Journal of Clinical Oncology. 39:e18724-e18724
e18724 Background: Active immunization seems to be the most effective protection against COVID-19. The objective of this prospective study was to explore the side effects of mRNA vaccine Tozinameran and possible differences in their incidence between
Autor:
JM Reuben, Gabriel Minarik, Massimo Cristofanilli, L Tothova, Michal Mego, Jozef Mardiak, Jan Luha, Pavol Janega, Denisa Manasova, Ivana Fridrichova, Juraj Pechan, Tatiana Sedlackova, P Celec, Barbora Vlková, Zuzana Cierna, Juraj Benca, Marian Karaba, Paulina Gronesova
Publikováno v:
Cancer Research. 73:P1-04
Background: Cancer is a risk factor for venous thromboembolism (VTE) and plasma D-dimer (DD) and tissue factor (TF) are established blood markers associated with VTE. CTCs are an independent predictor of survival in early and metastatic breast cancer
Publikováno v:
BMC Surgery
BMC Surgery, Vol 17, Iss 1, Pp 1-5 (2017)
BMC Surgery, Vol 17, Iss 1, Pp 1-5 (2017)
Background Limited data are available on the importance of routine lymphadenectomy of the hepatoduodenal ligament in the treatment of liver metastasis from colorectal cancer in the literature. Methods A single center retrospective cohort study was co
Autor:
I Rusnak, P Blasko, Michal Mego, Tomas Krivulcik, Ludovit Danihel, Vanda Repiská, Bozena Smolkova, Iveta Zmetakova, Marian Karaba, D Danis, Ivana Fridrichova, B Rychly, Juraj Benca, Viera Horvathova Kajabova, Juraj Pechan
Publikováno v:
Neoplasma. 60(6)
Breast carcinoma is the most common cancer with high mortality caused by metastatic disease. New molecular biomarkers predicting the tumour's metastatic potential would therefore improve metastasis prevention and personalised care. The aim of the stu
Autor:
James M. Reuben, Michal Mego, Juraj Pechan, Gabriela Sieberova, Gabriel Minarik, Jan Macuch, Jozef Sufliarsky, Veronika Svabova, Juraj Benca, Tomas Minarik, Z. Hlavata, Marian Karaba, Andrej Jurik, Jozef Mardiak, Tatiana Sedlackova, Eva Oravcova, Denisa Manasova, Paulina Gronesova
Publikováno v:
Journal of Clinical Oncology. 31:e22023-e22023
e22023 Background: CTCs are prognostic in breast cancer (BC) patients and represent a heterogeneous population of cells with different phenotypes and biological value. EMT gives rise to cells with stem cell-like properties with increased chemotherapy
Autor:
JM Reuben, Michal Mego, Juraj Benca, Gabriel Minarik, Jozef Mardiak, G Sieberova, Tatiana Sedlackova, Marian Karaba, Juraj Pechan, Paulina Gronesova, Denisa Manasova
Publikováno v:
Cancer Research. 72:P2-01
Background: Circulating tumor cells (CTCs) are prognostic in breast cancer (BC) patients. CTCs represent a heterogeneous population of cells with different phenotypes and biological value. Epithelial-mesenchymal transition (EMT) gives rise to cells w